Loading...

Brilliant Violet 785™ anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_BV785_F480_Antibody_FC_061614.jpg
Thioglycolate-elicited BALB/c mouse peritoneal macrophages were stained with F4/80 (clone BM8) Brilliant Violet 785™ (filled histogram) or rat IgG2a, κ Brilliant Violet 785™ isotype control (open histogram).
  • BM8_BV785_F480_Antibody_FC_061614.jpg
    Thioglycolate-elicited BALB/c mouse peritoneal macrophages were stained with F4/80 (clone BM8) Brilliant Violet 785™ (filled histogram) or rat IgG2a, κ Brilliant Violet 785™ isotype control (open histogram).
Compare all formats See Brilliant Violet 785™ spectral data
Cat # Size Price Save
123141 50 µg ¥60,500
Description

F4/80, also known as EMR1 or Ly71, is a 160 kD glycoprotein of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80 has been widely used as a murine macrophage marker. It is expressed on a majority of tissue macrophages, including macrophages in the lung, gut, peritoneal cavity, thymus, and red pulp of the spleen, Kupffer cells, Langerhans cells, microglia, and certain dendritic cells. It is not expressed on macrophages located in the T cell areas of the spleen, lymph node, or Peyer's patch. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for the induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 785™ under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 785™ excites at 405 nm and emits at 785 nm. The bandpass filter 780/60 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 785™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Application References

(PubMed link indicates BioLegend citation)
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Haratani K, et al. 2019. J Clin Invest. 130:374. PubMed
  2. Jiang W, et al. 2021. Sci Rep. 11:1864. PubMed
  3. Mugarza E, et al. 2022. Sci Adv. 8:eabm8780. PubMed
  4. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  5. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  6. Zhang L, et al. 2022. Immunol Cell Biol. 100:691. PubMed
  7. Schwarz N, et al. 2023. FASEB J. 37:e22846. PubMed
  8. Tong L, et al. 2023. Sci Adv. 9:eade5041. PubMed
  9. Choconta JL, et al. 2023. Immun Ageing. 20:22. PubMed
  10. Scott CL et al. 2018. Immunity. 49(2):312-325 . PubMed
  11. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  12. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  13. Kumaraswami K, et al. 2020. Int J Mol Sci. 21:00. PubMed
  14. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  15. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  16. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  17. Simic M, et al. 2020. Cell Reports. 32(6):108004. PubMed
  18. Bonnardel J, et al. 2019. Immunity. 51:638. PubMed
  19. Goossens P, et al. 2019. Cell Metab. 29:1376. PubMed
  20. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  21. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  22. de Reuver R, et al. 2021. Cell Reports. 36(6):109500. PubMed
  23. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  24. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  25. Guilliams M, et al. 2022. Cell. 185:379. PubMed
  26. Gentek R, et al. 2018. Immunity. 48:1160. PubMed
  27. Mossadegh–Keller N, et al. 2019. Bio Protoc. 9:5. PubMed
  28. Etzerodt A, et al. 2019. J Exp Med. 216:2394. PubMed
  29. Liu Y, et al. 2019. Nat Commun. 10:324. PubMed
  30. Riggs JB, et al. 2021. Front Microbiol. 12:656979. PubMed
  31. Knox T, et al. 2019. Sci Rep. 9:6136. PubMed
  32. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  33. Dai X, et al. 2021. Molecular Cell. 81(11):2317-2331.e6. PubMed
  34. Lee HY, et al. 2021. Curr Protoc. 1:e272. PubMed
  35. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  36. Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
  37. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  38. Bosteels C, et al. 2020. Immunity. 52(6):1039-1056.e9.. PubMed
  39. Hartwig T et al. 2017. Molecular cell. 65(4):730-742 . PubMed
  40. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  41. Phadke MS, et al. 2021. Cancer Immunol Res. 9:554. PubMed
  42. Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
  43. Subramanian S, et al. 2022. Nat Immunol. 23:458. PubMed
  44. Goddery EN, et al. 2021. Front Immunol. 12:726421. PubMed
  45. Etzerodt A, et al. 2020. J Exp Med. 217:00:00. PubMed
RRID
AB_2563667 (BioLegend Cat. No. 123141)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
F4/80
Specificity Alt (DOES NOT SHOW ON TDS):
F4/80
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about F4/80 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All F4/80 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 605™ anti-mouse F4/80 BM8 FC
Purified anti-mouse F4/80 BM8 FC,IHC,WB
Biotin anti-mouse F4/80 BM8 FC,IHC
FITC anti-mouse F4/80 BM8 FC
PE anti-mouse F4/80 BM8 FC
PE/Cyanine5 anti-mouse F4/80 BM8 FC
PE/Cyanine7 anti-mouse F4/80 BM8 FC
APC anti-mouse F4/80 BM8 FC
APC/Cyanine7 anti-mouse F4/80 BM8 FC
Alexa Fluor® 488 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse F4/80 BM8 FC
PerCP anti-mouse F4/80 BM8 FC
PerCP/Cyanine5.5 anti-mouse F4/80 BM8 FC
Alexa Fluor® 700 anti-mouse F4/80 BM8 FC
Brilliant Violet 421™ anti-mouse F4/80 BM8 FC,IHC-F,SB
Brilliant Violet 510™ anti-mouse F4/80 BM8 FC
Alexa Fluor® 594 anti-mouse F4/80 BM8 IHC-F
Brilliant Violet 785™ anti-mouse F4/80 BM8 FC
Purified anti-mouse F4/80 (Maxpar® Ready) BM8 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse F4/80 BM8 FC
Brilliant Violet 650™ anti-mouse F4/80 BM8 FC
Brilliant Violet 711™ anti-mouse F4/80 BM8 FC
APC/Fire™ 750 anti-mouse F4/80 BM8 FC
TotalSeq™-A0114 anti-mouse F4/80 BM8 PG
TotalSeq™-B0114 anti-mouse F4/80 BM8 PG
TotalSeq™-C0114 anti-mouse F4/80 BM8 PG
Spark YG™ 570 anti-mouse F4/80 BM8 IHC-F
KIRAVIA Blue 520™ anti-mouse F4/80 BM8 FC
Ultra-LEAF™ Purified anti-mouse F4/80 BM8 FC,IHC,WB
APC/Fire™ 810 anti-mouse F4/80 BM8 FC
Spark NIR™ 685 anti-mouse F4/80 BM8 FC
Spark Blue™ 550 anti-mouse F4/80 BM8 FC
Brilliant Violet 570™ anti-mouse F4/80 BM8 FC
Brilliant Violet 750™ anti-mouse F4/80 BM8 FC
PE/Fire™ 810 anti-mouse F4/80 BM8 FC
Spark Red™ 718 anti-mouse F4/80 (Flexi-Fluor™) BM8 FC
Spark Blue™ 574 anti-mouse F4/80 (Flexi-Fluor™) BM8 FC
Go To Top Version: 1    Revision Date: 06/27/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account